Literature DB >> 2133256

Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent.

J Han1, L Jiao, Y Lu, Z Sun, Q M Gu, K J Scanlon.   

Abstract

In this review, a retinoid analogue (N-4-hydroxycarbophenyl) retinamide (R11) has been evaluated for its pharmacological and clinical properties. R11 has been studied both as a cancer prevention agent, as well as, a cancer chemotherapeutic agent. R11 alone and in combination with other agents can be used for the treatment of cervical dysplasia or leukemia. This review will examine novel strategies and mechanisms of action for retinoids in the treatment and prevention of cancer.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2133256

Source DB:  PubMed          Journal:  In Vivo        ISSN： 0258-851X            Impact factor:   2.155


  4 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention.

Authors:  Susan R Mallery; Gary D Stoner; Peter E Larsen; Henry W Fields; Kapila A Rodrigo; Steven J Schwartz; Qingguo Tian; Jin Dai; Russell J Mumper
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

Review 3.  Chemoprevention of head and neck cancer.

Authors:  Katrina Y Glover; Vali A Papadimitrakopoulou
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

Review 4.  Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Authors:  Iván P Uray; Ethan Dmitrovsky; Powel H Brown
Journal:  Semin Oncol       Date:  2015-09-25       Impact factor: 4.929
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.